• Latest Posts
Podcast 12 May 2023

Beyond Biotech podcast 45: International MPS Awareness Day

Mezzion Pharma raises $40M for treatment option for heart surgery patients

LifeArc launches £40M funding call to create Translational Rare Disease Centres 

Orphalan announces U.S. launch of drug to treat Wilson disease

New technique developed for safer gene editing  

Pharming immunodeficiency drug given FDA approval

ADVERTISEMENT
Interview 3 Mar 2023

Interview: how has the first gene therapy for hemophilia B transformed research?

In Depth 3 Mar 2023

Let’s Take a Closer Look at 7 Autoimmune Diseases Biotechs are Fighting to Treat

European Commission approves first gene therapy for hemophilia B

GC Biopharma acquiring hemophilia rare disease pipeline

Opinion 28 Feb 2023

Life changing treatments for rare disease – a beacon of hope

ADVERTISEMENT